| Literature DB >> 34507928 |
Melanie Nana1, Catherine Nelson-Piercy2.
Abstract
Pregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns -surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women. © Royal College of Physicians 2021. All rights reserved.Entities:
Keywords: COVID-19; maternal outcomes; multidisciplinary care; pregnancy; vaccination
Mesh:
Substances:
Year: 2021 PMID: 34507928 PMCID: PMC8439502 DOI: 10.7861/clinmed.2021-0503
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 5.410